Key Metrics
SJR 

Q3Medicine (all)

Recommended pre-submission checks
Powered by 

International Journal of Pharmaceutical Compounding Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | International Journal of Pharmaceutical Compounding (Ijpc) |
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in International Journal of Pharmaceutical Compounding
Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Between Necessity and Compliance: Understanding FDA's GFI #256 for Animal Drug Compounding.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Design and Characterization of Doxepin In-situ Nasal Gel Using Pectin as a Bio-compatible Matrix.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Between Necessity and Compliance: Understanding FDA's GFI #256 for Animal Drug Compounding.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.
- 1 Feb 2026
- International journal of pharmaceutical compounding
Design and Characterization of Doxepin In-situ Nasal Gel Using Pectin as a Bio-compatible Matrix.
- 1 Feb 2026
- International journal of pharmaceutical compounding